Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved fo...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BOSTON and BEIJING, July 7, 2021 /PRNewswire-AsiaNet/ -- Eucure Biopharma, a wholly owned subsidiary of Biocytogen( http://www.biocytogen.com/ ) dedicated to developing antibody drugs with independent intellectual property rights, announced that the U.S. Food and Drug Administration (FDA) has approved t...
Authors: LATEST ASIANET NEWS RELEASES